These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25112308)
1. A study of up to 12 years of follow-up of Friedreich ataxia utilising four measurement tools. Tai G; Corben LA; Gurrin L; Yiu EM; Churchyard A; Fahey M; Hoare B; Downie S; Delatycki MB J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):660-6. PubMed ID: 25112308 [TBL] [Abstract][Full Text] [Related]
2. How is disease progress in Friedreich's ataxia best measured? A study of four rating scales. Fahey MC; Corben L; Collins V; Churchyard AJ; Delatycki MB J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):411-3. PubMed ID: 17056635 [TBL] [Abstract][Full Text] [Related]
3. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Ribaï P; Pousset F; Tanguy ML; Rivaud-Pechoux S; Le Ber I; Gasparini F; Charles P; Béraud AS; Schmitt M; Koenig M; Mallet A; Brice A; Dürr A Arch Neurol; 2007 Apr; 64(4):558-64. PubMed ID: 17420319 [TBL] [Abstract][Full Text] [Related]
5. How does performance of the Friedreich Ataxia Functional Composite compare to rating scales? Tai G; Yiu EM; Delatycki MB; Corben LA J Neurol; 2017 Aug; 264(8):1768-1776. PubMed ID: 28695363 [TBL] [Abstract][Full Text] [Related]
6. HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia. Delatycki MB; Tai G; Corben L; Yiu EM; Evans-Galea MV; Stephenson SE; Gurrin L; Allen KJ; Lynch D; Lockhart PJ Mov Disord; 2014 Jun; 29(7):940-3. PubMed ID: 24390816 [TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of the Friedreich Ataxia Impact Scale. Tai G; Yiu EM; Corben LA; Delatycki MB J Neurol Sci; 2015 May; 352(1-2):53-7. PubMed ID: 25840637 [TBL] [Abstract][Full Text] [Related]
8. Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review. Jain P; Badgujar L; Spoorendonk J; Buesch K Ther Adv Rare Dis; 2022; 3():26330040221139872. PubMed ID: 37180421 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of spatiotemporal gait parameters in measuring disease severity in Friedreich ataxia. Milne SC; Hocking DR; Georgiou-Karistianis N; Murphy A; Delatycki MB; Corben LA Cerebellum; 2014 Dec; 13(6):677-88. PubMed ID: 25022367 [TBL] [Abstract][Full Text] [Related]
14. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998 [TBL] [Abstract][Full Text] [Related]
15. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB; Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651 [TBL] [Abstract][Full Text] [Related]
16. Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. Pandolfo M; Arpa J; Delatycki MB; Le Quan Sang KH; Mariotti C; Munnich A; Sanz-Gallego I; Tai G; Tarnopolsky MA; Taroni F; Spino M; Tricta F Ann Neurol; 2014 Oct; 76(4):509-21. PubMed ID: 25112865 [TBL] [Abstract][Full Text] [Related]